Market Overview

Cresco Labs Continues First to Market Strategy in Ohio by Facilitating First Legal Sale of Medical Marijuana under State Program

Share:

Cresco
Labs
(CSE:CL) ("Cresco" or "the Company"), one of the largest
vertically integrated multistate cannabis operators in the United
States, today announced the opening and first legal sale of medical
marijuana in the state of Ohio at its CY+ dispensary, making this the
second state medical marijuana program in which the Company has been
first to market.

"In Ohio, we are continuing our pattern of ‘firsts' across the U.S. As a
multi-state operator, we have repeatedly proven our ability to gain
access to selected markets, get operational, distribute product and
claim a first mover advantage in market share," said Charlie Bachtell,
CEO of Cresco Labs. "Following our similar achievement in Pennsylvania
where we were the first operator to be approved and come to market as a
cultivator, Ohio is the second state in a row where our expeditious path
to market positioned us to serve the patients of the state by making the
first legal sale of marijuana, officially launching Ohio's statewide
medical marijuana program."

Cresco Labs' new dispensary, named CY+ (pronounced "see why plus"),
opened its doors on January 16 and offers a wide selection of
pharmaceutical-grade marijuana for physician-certified patients across
Ohio. In December 2018, Cresco Labs was granted the first certificate of
operation for a medical marijuana dispensary in the state, over a month
before other cannabis operators received the same approvals.

"Cresco has repeatedly scaled the steepest learning curves in the most
highly regulated markets to get operational and to establish a dominant
market position," Bachtell added. "Our achievement in Ohio again shows
Cresco Labs' ability to efficiently put capital to use for the benefit
of state programs, patients and our shareholders."

In addition to the Wintersville dispensary, the Company has built an
environmentally advanced 50,000-square-foot growing and cultivation
facility located in Yellow Springs, Ohio that will supply statewide
dispensaries.

CY+ will launch with flower only products but, in addition to other
brands, will eventually carry Cresco's full brand suite—Cresco, Remedi,
Reserve, and Mindy's Edibles, an infused edible line created by James
Beard Award-winning chef Mindy Segal — providing a full suite of
consistently dosed products catering to all consumers.

CY+ is located at 180 Main Street in Wintersville, Ohio and can be
reached at 740/617-8649.

About Cresco Labs:

Cresco Labs, based in Chicago, is a leading U.S. cannabis company with
experienced management, access to capital and a demonstrated growth
strategy. As a differentiated grower, processor and retailer of premium
cannabis operating in seven states, the company focuses on entering
highly regulated markets with outsized demand potential and high
barriers to entry. Its impressive speed-to-market gives Cresco a
distinct competitive advantage as it replicates its model to expand its
national footprint. Cresco's proven ability to execute is complemented
by a cutting-edge brand strategy spearheaded by several of the brightest
minds in consumer marketing in the nation. Cresco's products are
tailored to all major consumer segments: everyday cannabis, medicinally
focused, connoisseur grade, and chef inspired edibles by James Beard
Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.

Forward Looking Statements

This press release contains "forward-looking information" within the
meaning of applicable Canadian securities legislation and may also
contain statements that may constitute "forward-looking statements"
within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Such forward-looking
information and forward-looking statements are not representative of
historical facts or information or current condition, but instead
represent only the Company's beliefs regarding future events, plans or
objectives, many of which, by their nature, are inherently uncertain and
outside of the Company's control. Generally, such forward-looking
information or forward-looking statements can be identified by the use
of forward-looking terminology such as, ‘may,' ‘will,' ‘should,'
‘could,' ‘would,' ‘expects,' ‘plans,' ‘anticipates,' ‘believes,'
‘estimates,' ‘projects,' ‘predicts,' ‘potential' or ‘continue' or the
negative of those forms or other comparable terms. The Company's
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the Company's actual
results, performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by the
forward-looking statements, including but not limited to those risks
discussed under "Risk Factors" in the company's CSE Listing Statement
filed with SEDAR; and other factors, many of which are beyond the
control of the Company. Readers are cautioned that the foregoing list of
factors is not exhaustive. Because of these uncertainties, you should
not place undue reliance on the Company's forward-looking statements. No
assurances are given as to the future trading price or trading volumes
of Cresco's shares, nor as to the Company's financial performance in
future financial periods. The Company does not intend to update any of
these factors or to publicly announce the result of any revisions to any
of the Company's forward-looking statements contained herein, whether as
a result of new information, any future event or otherwise. Except as
otherwise indicated, this press release speaks as of the date hereof.
The distribution of this press release does not imply that there has
been no change in the affairs of the Company after the date hereof or
create any duty or commitment to update or supplement any information
provided in this press release or otherwise.

View Comments and Join the Discussion!